Surgical biopsy is safe for certain late-stage lung cancer patients and could improve their chances of getting treated with newer types of drugs that target cancer-related genetic mutations, a new small study reveals. However, these less invasive techniques sometimes gather too few tumor cells to perform the molecular testing needed to prescribe newer targeted drugs, the researchers said.

READ FULL ARTICLE Curated publisher From Drugs.com